INNOVIS HEALTH — History
CCN 350070 | 3-year financial timeline | COVID resilience: 53/100
🛡️ Public data only — no PHI permitted on this instance.
$538M
Latest Revenue (FY2022)
+12.4%
Revenue CAGR (3yr)
-5.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $426M | $462M | $538M | +16.5% | +12.4% |
| Operating Expenses | $423M | $482M | $566M | +17.4% | +15.7% |
| Operating Margin | 0.7% | -4.4% | -5.3% | -18.4% | +0.0% |
| Net Income | $3M | $-20M | $-28M | -38.0% | +0.0% |
| Licensed Beds | 149 | 142 | 142 | +0.0% | -2.4% |
| Total Patient Days | 36,578 | 41,120 | 44,975 | +9.4% | +10.9% |
| Medicare Day % | 36% | 35% | 38% | +9.8% | +3.1% |
| Medicaid Day % | 14% | 9% | 8% | -9.6% | -21.6% |
COVID Impact & Recovery
Resilience Score: 53/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +26.3% ($426M → $538M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+12.4%
This Hospital
+7.6%
State Avg
Latest Margin
-5.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $594M | -8.2% |
| FY2024 (proj) | $650M | -11.2% |
| FY2025 (proj) | $706M | -14.2% |